Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

NCT01776788 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: insulin lispro injection, exenatide injection
DRUG: insulin lispro injection

Sponsor

The First Affiliated Hospital of Xiamen University